ALYSSA SMOAK: Open Payments
NPI 1174136816 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 59 payments from 21 companies in 2025. Trend: 2023 $1,700 · 2024 $1,645 · 2025 $1,612
Food & beverage: $1,612
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 2 | $260 |
| Edwards Lifesciences Corporation | 3 | $176 |
| E.R. Squibb & Sons, L.L.C. | 13 | $171 |
| Novo Nordisk Inc | 5 | $138 |
| Philips North America LLC | 5 | $137 |
| AltaThera Pharmaceuticals LLC | 1 | $125 |
| Alnylam Pharmaceuticals Inc. | 3 | $85 |
| Amgen Inc. | 4 | $73 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Esperion Therapeutics, Inc. | 3 | $53 |
Products named: Assure WCD, EVOQUE, Wegovy, Sotalol Hydrochloride, CAMZYOS, ONPATTRO, ELIQUIS, REPATHA.
Industry payments across SC — which companies pay providers there.
